Allergic Rhinitis – A Complete Patient‑Friendly Guide

Overview

Allergic rhinitis (often called hay fever) is an inflammation of the nasal lining caused by an immune response to airborne allergens such as pollen, dust‑mite proteins, pet dander, or mold spores. The condition is not contagious.

It affects people of all ages, but it is most common in children and young adults. In the United States, about 20 % of the population (≈ 60 million people) experience symptoms each year, while worldwide prevalence ranges from 10 % to 30 % depending on geography and allergen exposure [1].

There are two major forms:

• Seasonal allergic rhinitis – triggered by pollens that spike during spring, summer, or fall.
• Perennial allergic rhinitis – caused by year‑round allergens such as dust mites, pet dander, or indoor molds.

Symptoms

Symptoms arise when the immune system releases histamine and other inflammatory mediators. The classic “triad” includes nasal congestion, rhinorrhea (runny nose), and sneezing, but many patients experience a broader spectrum:

Upper‑respiratory symptoms

• Sneezing – often in rapid bursts (4–5 times or more).
• Runny nose – thin, clear discharge that may become thicker later in the day.
• Nasal congestion – a feeling of blockage that can worsen when lying down.
• Itchy nose, palate, or throat – provides the urge to rub the nose.
• Post‑nasal drip – sensation of mucus running down the back of the throat, causing cough or throat clearing.

Ocular (eye) symptoms

• Itchy, watery, or red eyes (allergic conjunctivitis).
• Swollen eyelids (blepharitis) in severe cases.

Other possible manifestations

• Fatigue – disrupted sleep from nasal blockage.
• Headache or facial pressure.
• Reduced sense of smell (hyposmia) or altered taste.
• Ear fullness or mild hearing loss due to eustachian tube dysfunction.

Causes and Risk Factors

Allergic rhinitis results from an over‑active immune response (IgE‑mediated) to otherwise harmless substances.

Primary allergens

• Pollen – trees (spring), grasses (summer), ragweed & weeds (fall).
• Dust mites – microscopic arthropods that live in bedding, carpets, and upholstery.
• Pet dander – skin flakes or saliva proteins from cats, dogs, rodents.
• Mold spores – indoor (e.g., Cladosporium) and outdoor (e.g., Alternaria).

Risk factors

• Family history of atopy (asthma, eczema, food allergies).
• Personal history of other allergic diseases.
• Living in urban areas with higher pollen counts or indoor allergen exposure.
• Exposure to tobacco smoke or air pollution, which can amplify inflammatory responses.
• Occupations involving dust, chemicals, or animal handling (e.g., farming, laboratory work).

Diagnosis

Diagnosis is primarily clinical, based on history and physical examination. A systematic approach helps differentiate allergic rhinitis from other conditions such as infectious rhinitis, non‑allergic rhinitis, or nasal polyps.

History taking

• Timing of symptoms (seasonal vs. perennial).
• Relation to specific exposures (e.g., being around pets, opening windows).
• Associated eye symptoms, asthma, or eczema.
• Impact on sleep, work, or school performance.

Physical examination

• Inspection of nasal mucosa – pale, edematous, and cobblestoned appearance.
• Allergic shiners (dark circles under eyes) or Dennie‑Morgan folds (infra‑orbital folds).
• Ocular examination – conjunctival injection.

Allergy testing (optional but useful)

1. Skin‑prick test (SPT) – drops of standardized allergen extracts are placed on the forearm or back; a wheal ≥3 mm suggests sensitization. Results are available within 15‑20 minutes.
2. Serum specific IgE testing (e.g., ImmunoCAP) – a blood draw measuring IgE antibodies to particular allergens; helpful when skin testing is contraindicated (e.g., skin disease, antihistamine use).

Both tests have >85 % sensitivity and specificity when performed by trained professionals [2].

Imaging & other studies

• Usually not required. Sinus CT may be ordered only if chronic sinusitis or nasal polyps are suspected.

Treatment Options

Treatment aims to relieve symptoms, minimize allergen exposure, and prevent complications. Management is usually stepwise (similar to the ARIA guidelines – Allergic Rhinitis and its Impact on Asthma).

1. Allergen avoidance (first line)

• Keep windows closed during high pollen counts; use air conditioners with HEPA filters.
• Encourage pets to stay out of bedrooms; wash hands after handling animals.
• Use dust‑mite‑proof covers on mattresses and pillows; wash bedding weekly in water ≥ 60 °C.
• Reduce indoor humidity < 50 % to limit mold growth (dehumidifiers, proper ventilation).

2. Pharmacologic therapy

Intranasal corticosteroids (INCS)

First‑line for most patients; reduce inflammation at the source.

• Examples: fluticasone propionate (Flonase), mometasone furoate (Nasonex), budesonide (Rhinocort).
• Typical dose: 1–2 sprays per nostril once daily.
• Onset of relief: 12–24 h; maximal effect after 1–2 weeks.
• Side effects: mild nasal irritation, occasional epistaxis; systemic effects are rare.

Antihistamines

• Second‑generation oral antihistamines (cetirizine, loratadine, fexofenadine) – non‑sedating, good for sneezing and itching.
• Intranasal antihistamines (azelastine, olopatadine) – useful as add‑on or monotherapy for mild disease.

Decongestants

• Oral pseudoephedrine or phenylephrine – short‑term relief of severe congestion (≤ 3 days).
• Topical (oxymetazoline, phenylephrine) – effective but limited to 3‑5 days to avoid rebound congestion (rhinitis medicamentosa).

Leukotriene receptor antagonists (LTRAs)

Montelukast can be considered, especially when allergic rhinitis coexists with asthma or aspirin‑sensitive respiratory disease. Evidence shows modest benefit as add‑on therapy [3].

Immunotherapy

• Subcutaneous immunotherapy (SCIT) – weekly injections of gradually increasing allergen extracts for 3‑5 years. Reduces symptoms and medication need in 60‑80 % of patients.
• Sublingual immunotherapy (SLIT) – daily tablets or drops placed under the tongue; approved for grass, ragweed, and dust‑mite allergens in the U.S.
• Best suited for patients with clear sensitization, moderate‑to‑severe disease, or who cannot avoid triggers.

3. Procedural/interventional options

• Radiofrequency turbinate reduction – minimally invasive shrinking of enlarged inferior turbinates to improve airflow; considered when medical therapy fails.
• Septoplasty – corrects deviated septum that can worsen congestion; done only after allergic component is controlled.

4. Lifestyle & adjunctive measures

• Saline nasal irrigation (neti pot or squeeze bottle) – 2–3 times daily helps clear mucus and allergens.
• Humidifiers – use cool‑mist in dry climates; clean regularly to prevent mold.
• Regular exercise – improves nasal airflow and overall immunity.

Living with Allergic Rhinitis

Effective self‑management empowers patients to keep symptoms under control and maintain quality of life.

Daily routine tips

• Morning – Perform a saline rinse before heading out; take your INCS and/or antihistamine as prescribed.
• During high pollen days – Check local pollen counts (weather apps, National Allergy Bureau). Keep windows shut, limit outdoor activities in the early morning.
• Evening – Shower and change clothes after being outdoors to remove pollen; wash bedding weekly.

Travel considerations

• Carry a portable saline kit and a rescue inhaler (if you have asthma).
• Research hotel allergen‑control policies (e.g., hypo‑allergenic rooms, air filtration).

Work/school accommodations

• Request a “allergy‑friendly” workspace (dust‑free, HEPA‑filtered).
• Keep a short‑acting antihistamine at your desk for breakthrough symptoms.

Monitoring tools

• Use a symptom diary or mobile app to track trigger exposure, medication use, and symptom severity.
• Periodically reassess with your clinician; effectiveness of therapy may wane as allergen patterns shift.

Prevention

While you cannot eliminate all allergens, you can lower exposure and strengthen your body’s tolerance.

• Maintain indoor humidity below 50 % and clean air ducts annually.
• Use vacuum cleaners equipped with HEPA filters; vacuum twice weekly.
• Consider allergen‑proof bedding and wash all fabrics in hot water.
• For seasonal sufferers, start prophylactic INCS or antihistamines 1–2 weeks before anticipated pollen peaks.
• Stay up‑to‑date on immunotherapy if recommended; it can modify the disease course long‑term.

Complications

If left untreated or inadequately controlled, allergic rhinitis may lead to:

• Sinusitis – chronic inflammation can become infected, causing facial pain and prolonged congestion.
• Otitis media with effusion – fluid buildup behind the eardrum, especially in children, may affect hearing.
• Sleep disturbances – nasal obstruction leads to snoring or obstructive sleep apnea.
• Asthma exacerbation – upper‑airway inflammation can worsen lower‑airway hyper‑responsiveness.
• Reduced quality of life – impacts academic performance, work productivity, and mood (higher rates of anxiety/depression reported).

When to Seek Emergency Care

---

Sources:

• [1] Centers for Disease Control and Prevention. Allergy Overview. 2023.
• [2] Pawankar R, et al. “Allergic Rhinitis: Pathophysiology and Diagnosis.” J Allergy Clin Immunol. 2022;149(2):369‑381.
• [3] Singh S, et al. “Leukotriene Receptor Antagonists in Allergic Rhinitis: A Systematic Review.” Allergy. 2021;76(7):2351‑2362.
• Mayo Clinic. Hay Fever (Allergic Rhinitis). Updated 2024.
• World Health Organization. Allergic Diseases Fact Sheet. 2023.